Tobacco industry strategies to attract young smokers in Spain: A review of companies' internal documents

Translational Hispanic Health Research Initiative, College of Education, University of Texas at El Paso, Texas 79968, USA.
Adicciones (Impact Factor: 1.15). 01/2011; 23(4):327-34.
Source: PubMed


Tobacco companies' strategies to promote tobacco use and undermine tobacco control policy are key in tobacco use among young people. The analysis of tobacco companies' internal documents can be instrumental in identifying those strategies, improving social support for tobacco control policy, and planning public health interventions. The goal of this study was to identify and analyze internal documents related to the activities of tobacco companies during the 1980s and 90s aimed at promoting smoking in young Spaniards.
Electronic search by key word of tobacco industry documents held at the Legacy Tobacco Documents Library.
More than 1,000 documents were identified and reviewed, including letters, messages, memos, and other documents. Seventeen documents related to the objective of the study are analyzed and discussed.
Tobacco companies funded and conducted activities aimed at maintaining high smoking incidence and prevalence in Spain. These activities, which included research, cigarette and packaging design, promotion, and social and political manipulation, may have had an impact on current levels of tobacco use in Spain.


Available from: Francisco Soto Mas
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aim: To compare healthcare resource utilization and costs according to smoking status in patients with type 2 diabetes in clinical practice. Methods: A retrospective cohort nested case-control study was designed. Cases were current smokers, while 2 types of controls (former smokers and never smokers) were matched (2 controls per case) for age, sex, duration of diabetes and burden of comorbidity using data from medical records. Noninstitutionalized diabetics of both genders, aged>18 years and seen consecutively over a 5-year period before the index date, were enrolled. Analysis compared healthcare resource utilization, loss of productivity due to sick leave and corresponding costs. Results: In total, 2,490 medical records were analyzed, i.e. 498 cases, 996 former smokers and 996 never smokers. Mean age was 63.4 years (64.9% male). Smokers had higher glycosylated hemoglobin levels (7.4 vs. 7.2 and 7.2%, respectively; p=0.013) and a lower degree of metabolic control (49.2 vs. 54.7 and 55.8%; p=0.036). Smokers had higher average annual costs (EUR 3,583) than former smokers (EUR 2,885; p<0.001) and never smokers (EUR 2,183; p<0.001). Conclusions: Diabetic smoker patients had lower metabolic control, higher health resource utilization and more sick leave, resulting in higher healthcare costs and lost productivity compared with both former and never smoker diabetics.
    European Addiction Research 10/2013; 20(2):94-104. DOI:10.1159/000355171 · 2.10 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chronic obstructive pulmonary disease (COPD) is a prevalent condition mainly related to smoking, which is associated with a substantial economic burden. The purpose was to compare healthcare resource utilization and costs according to smoking status in patients with COPD in routine clinical practice. A retrospective cohort nested case-control study was designed. The cohort was composed of male and female COPD outpatients, 40 years or older, covered by the Badalona Serveis Assistencials (a health provider) health plan. Cases were current smokers with COPD and controls (two per case) were former smokers with COPD (at least 12 months without smoking), matched for age, sex, duration of COPD, and burden of comorbidity. The index date was the last visit recorded in the database, and the analysis was performed retrospectively on healthcare resource utilization data for the 12 months before the index date. A total of 930 COPD records were analyzed: 310 current and 620 former smokers [mean age 69.4 years (84.6 % male)]. Cases had more exacerbations, physician visits of any type, and drug therapies related to COPD were more common. As a consequence, current smokers had higher average annual healthcare costs: 3,784 (1,888) versus 2,302 (2,451), p < 0.001. This difference persisted after adjusting for severity of COPD. Current smokers with COPD had significantly higher use of healthcare resources, mainly COPD drugs and physician visits, compared with former smokers who had abstained for at least 12 months. As a consequence, current smokers had higher healthcare costs to the National Health System in Spain than ex-smokers.
    Beiträge zur Klinik der Tuberkulose 05/2014; 192(4). DOI:10.1007/s00408-014-9592-7 · 2.27 Impact Factor